Johnson & Johnson
Coronavirus digest: Johnson & Johnson applies for emergency approval in US
Johnson & Johnson has become the latest company to request emergency authorization for its vaccine in the US, hoping to produce 1 billion jabs this year. Follow DW for the latest.
S.Africa to begin Covid vaccine rollout with Johnson & Johnson jab
South Africa plans to kickstart its Covid-19 vaccination campaign with Johnson & Johnson jabs after withholding a batch of AstraZeneca doses following doubts over the shot's efficacy. The country worst-hit by the pandemic in Africa had suspended its vaccine rollout - meant to begin with Oxford/AstraZeneca - after scientists found the shot failed to prevent mild and moderate illness caused by a local virus variant known as 501Y.V2.